Pharmaceutical superdisintegrant

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6660303
APP PUB NO 20020068084A1
SERIAL NO

09731238

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Superdisintegrants which provide improved compressibility compared to prior art superdisintegrants and which does not negatively impact the compressibility of formulations which include high-dose drugs, and methods for obtaining the same are disclosed. The superdisintegrants include a particulate agglomerate of coprocessed starch or cellulose and a sufficient amount of an augmenting agent to increase the compactibility of the superdisintegrant. The augmented superdisintegrant provides a fast disintegration of a solid dosage form when incorporated in sufficient quantity therein, without untowardly affecting the compactibility of the solid dosage form (relative to the solid dosage form without the superdisintegrant).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
J RETTENMAIER & SOEHNE GMBH + CO KGHOLZMUEHLE 1 ROSENBERG 73494

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Staniforth, John Bath, GB 29 612

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation